Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | F2 | P00734 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14579660 | 0.96 | GLA (0.61) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL12925820 | 0.96 | GLA (0.61) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL14579657 | 0.96 | GLA (0.61) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL30595409 | 0.91 | CA12 (0.65) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL3974361 | 0.91 | CA12 (0.65) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL5352558 | 0.87 | CA12 (0.61) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL29705954 | 0.87 | CA12 (0.61) | GLAALDH1A1F2HPGDKDM4E | |
| SCHEMBL20414569 | 0.87 | AKR1C3 (0.60) | GLAALDH1A1F2HPGDCYP1A2 | |
| SCHEMBL361383 | 0.83 | LMNA (0.66) | GLAALDH1A1F2HPGDLMNA | |
| SCHEMBL30155392 | 0.83 | KMT2A (0.61) | GLAALDH1A1KDM4ECA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113308704-B | Electrooxidation preparation method of naproxen intermediate | 湖南大学 | 2022-04-08 | — | — | CN | claimed |
| CN-113308704-A | Electrooxidation preparation method of naproxen intermediate | 湖南大学 | 2021-08-27 | — | — | CN | claimed |
| US-8088150-B2 | Device for disc shunt implantation and peri-shunt injection | ALEEVA MEDICAL INC. (US) | 2012-01-03 | — | — | US | claimed |
| US-20090198248-A1 | Device for disc shunt implantation and peri-shunt injection | YEUNG JEFFREY E | 2009-08-06 | — | — | US | claimed |
| EP-1197227-B9 | METHOD OF THE ADMINISTRATION OF DRUGS HAVING BINDING AFFINITY WITH PLASMA PROTEIN AND PREPARATION TO BE USED IN THE METHOD | NIHON MEDIPHYSICS CO LTD (JP) | 2008-06-11 | — | — | EP | claimed |
| EP-1197227-B1 | METHOD OF THE ADMINISTRATION OF DRUGS HAVING BINDING AFFINITY WITH PLASMA PROTEIN AND PREPARATION TO BE USED IN THE METHOD | NIHON MEDIPHYSICS CO LTD (JP) | 2007-09-12 | — | — | EP | claimed |
| US-20230277504-A1 | COMPOSITIONS AND METHODS COMPRISING CELECOXIB OR RELATED COMPOUNDS AND DEXTROMETHORPHAN | ANTECIP BIOVENTURES II LLC | 2023-09-07 | — | — | US | disclosed |
| US-20230266683-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230266684-A1 | IMAGE FORMING UNIT AND IMAGE FORMING APPARATUS | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230266684-A1 | IMAGE FORMING UNIT AND IMAGE FORMING APPARATUS | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230266683-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2023-08-24 | — | — | US | disclosed |
| CN-113308704-B | Electrooxidation preparation method of naproxen intermediate | 湖南大学 | 2022-04-08 | — | — | CN | disclosed |
| CN-113308704-B | Electrooxidation preparation method of naproxen intermediate | 湖南大学 | 2022-04-08 | — | — | CN | disclosed |
| US-20060223779-A1 | Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 | PRESCOTT STEPHEN M | 2006-10-05 | — | — | US | disclosed |
| EP-1311660-A4 | METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 | UNIV UTAH RES FOUND (US) | 2004-07-28 | — | — | EP | disclosed |
| EP-1311660-A1 | METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 | University of Utah Research Foundation (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002016575-A1 | METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-02-28 | — | — | WO | disclosed |
| EP-0759750-A4 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1998-05-27 | — | — | EP | disclosed |
| EP-0759750-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO, Howard, K. (US) | 1997-03-05 | — | — | EP | disclosed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277504-A1 | COMPOSITIONS AND METHODS COMPRISING CELECOXIB OR RELATED COMPOUNDS AND DEXTROMETHORPHAN | CYP2E1, CYP2D6, CYP3A43 | GLA 3243/4885ALDH1A1 1027/4885F2 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.